{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:10:16Z","timestamp":1772784616837,"version":"3.50.1"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["317316"],"award-info":[{"award-number":["317316"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007181","name":"Biotechnology Research Center, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI121700"],"award-info":[{"award-number":["R21AI121700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI050875"],"award-info":[{"award-number":["R01AI050875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijbiomac.2020.09.204","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T12:39:59Z","timestamp":1601296799000},"page":"18-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"PA","title":["Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials"],"prefix":"10.1016","volume":"165","author":[{"given":"Fatemeh","family":"Oroojalian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Haghbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Hemmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Ali","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein Bannazadeh","family":"Baghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahad","family":"Mokhtarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijbiomac.2020.09.204_bb0005","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","article-title":"History and recent advances in coronavirus discovery","volume":"24","author":"Kahn","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.09.204_bb0010","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/v4113044","article-title":"Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies","volume":"4","author":"Geller","year":"2012","journal-title":"Viruses"},{"issue":"4 Pt B","key":"10.1016\/j.ijbiomac.2020.09.204_bb0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","article-title":"Human coronaviruses: what do they cause?","volume":"12","author":"van der Hoek","year":"2007","journal-title":"Antivir. Ther."},{"issue":"14","key":"10.1016\/j.ijbiomac.2020.09.204_bb0020","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0025","first-page":"1","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","author":"C.S.G. of the International","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0030","series-title":"Coronavirus Disease 2019 (COVID-19): Situation Report-76","author":"W.H. Organization","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-virology-100114-055218","article-title":"Continuous and discontinuous RNA synthesis in coronaviruses","volume":"2","author":"Sola","year":"2015","journal-title":"Annual review of virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2013.08.014","article-title":"Receptor recognition and cross-species infections of SARS coronavirus","volume":"100","author":"Li","year":"2013","journal-title":"Antivir. Res."},{"issue":"5664","key":"10.1016\/j.ijbiomac.2020.09.204_bb0045","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1126\/science.1092002","article-title":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China","volume":"303","author":"C.S.M.E. Consortium","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.09.204_bb0050","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.7150\/ijbs.45053","article-title":"SARS-CoV-2: an emerging coronavirus that causes a global threat","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.09.204_bb0060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Dandekar","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1309\/WPK7Y2XKNF4CBF3R","article-title":"The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome","volume":"121","author":"B.G. National Research Project for SARS","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0070","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","article-title":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice","volume":"173","author":"Glass","year":"2004","journal-title":"J. Immunol."},{"issue":"49","key":"10.1016\/j.ijbiomac.2020.09.204_bb0075","doi-asserted-by":"crossref","first-page":"17039","DOI":"10.1073\/pnas.0407992101","article-title":"Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0080","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/JVI.79.4.2079-2086.2005","article-title":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3","volume":"79","author":"Spiegel","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virusres.2004.09.004","article-title":"SARS-coronavirus replication in human peripheral monocytes\/macrophages","volume":"107","author":"Yilla","year":"2005","journal-title":"Virus Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.09.204_bb0090","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in sars-coronavirus\u2013infected, monocyte-derived human dendritic cells","volume":"106","author":"Law","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.09.204_bb0095","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1128\/JVI.78.11.5612-5618.2004","article-title":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"issue":"7403","key":"10.1016\/j.ijbiomac.2020.09.204_bb0100","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.09.204_bb0105","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1469-0691.2004.01009.x","article-title":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus","volume":"10","author":"Hsueh","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"issue":"26","key":"10.1016\/j.ijbiomac.2020.09.204_bb0110","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0125","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3389\/fimmu.2018.02180","article-title":"Flavivirus receptors: diversity, identity, and cell entry","volume":"9","author":"Laureti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0130","first-page":"8","article-title":"Targeting viral entry as a strategy for broad-spectrum antivirals","author":"Mazzon","year":"2019","journal-title":"F1000Res"},{"issue":"42","key":"10.1016\/j.ijbiomac.2020.09.204_bb0135","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1073\/pnas.1407087111","article-title":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein","volume":"111","author":"Millet","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme","volume":"43","author":"White","year":"2008","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1\u20134","key":"10.1016\/j.ijbiomac.2020.09.204_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00709-010-0152-6","article-title":"Mechanisms of viral entry: sneaking in the front door","volume":"244","author":"Thorley","year":"2010","journal-title":"Protoplasma"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0150","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.3390\/v7062747","article-title":"Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis","volume":"7","author":"Boulant","year":"2015","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MNH.0b013e328341164a","article-title":"Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease","volume":"20","author":"Tikellis","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0160","doi-asserted-by":"crossref","first-page":"307315","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-converting enzyme 2: the first decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int. J. Hypertens."},{"issue":"7798","key":"10.1016\/j.ijbiomac.2020.09.204_bb0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0170","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0180","series-title":"SARS-CoV-2 Invades Host Cells Via a Novel Route: CD147-spike Protein","author":"Wang","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0185","first-page":"1444","article-title":"Role of CD147 (EMMPRIN\/basigin) in tissue remodeling","volume":"367","author":"Guindolet","year":"2020","journal-title":"Anat. Rec."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/1178636118825081","article-title":"Characterization of pathogenic sepsis etiologies and patient profiles: a novel approach to triage and treatment","volume":"12","author":"Dolin","year":"2019","journal-title":"Microbiol Insights"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1099\/jmm.0.45561-0","article-title":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection","volume":"53","author":"Chen","year":"2004","journal-title":"J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.09.204_bb0200","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0205","doi-asserted-by":"crossref","first-page":"e00283","DOI":"10.1042\/BSR20150256","article-title":"How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity","volume":"36","author":"Grass","year":"2015","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0215","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"5742","key":"10.1016\/j.ijbiomac.2020.09.204_bb0220","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jmv.25726","article-title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2","volume":"92","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0235","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0240","doi-asserted-by":"crossref","first-page":"15701","DOI":"10.1038\/s41598-018-34171-7","article-title":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis","volume":"8","author":"Kirchdoerfer","year":"2018","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.ijbiomac.2020.09.204_bb0245","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0250","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.11.054","article-title":"The SARS-CoV S glycoprotein: expression and functional characterization","volume":"312","author":"Xiao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104759","article-title":"A potential role for integrins in host cell entry by SARS-CoV-2","volume":"177","author":"Sigrist","year":"2020","journal-title":"Antivir. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.09.204_bb0260","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1074\/jbc.M111.325803","article-title":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus","volume":"287","author":"Wu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0265","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0270","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/tra.12387","article-title":"Principles of virus uncoating: cues and the snooker ball","volume":"17","author":"Yamauchi","year":"2016","journal-title":"Traffic"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0275","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0280","doi-asserted-by":"crossref","first-page":"e1008392","DOI":"10.1371\/journal.ppat.1008392","article-title":"Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry","volume":"16","author":"Shang","year":"2020","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0285","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/v4040557","article-title":"Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence","volume":"4","author":"Heald-Sargent","year":"2012","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.09.204_bb0290","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00705-017-3497-8","article-title":"A comparative review of viral entry and attachment during large and giant dsDNA virus infections","volume":"162","author":"Sobhy","year":"2017","journal-title":"Arch. Virol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01429-17","article-title":"Tetraspanins: architects of viral entry and exit platforms","volume":"93","author":"Hantak","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0300","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0310","first-page":"11876","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"102","author":"Hoffmann","year":"2005","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.09.204_bb0315","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"issue":"33","key":"10.1016\/j.ijbiomac.2020.09.204_bb0320","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00998-13","article-title":"Novel inhibitors of SARS-CoV entry acting by three distinct mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2011.12.012","article-title":"A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2","volume":"94","author":"Struck","year":"2012","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40264-014-0239-7","article-title":"The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases","volume":"38","author":"Abraham","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0340","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.09.204_bb0345","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.3346\/jkms.2020.35.e88","article-title":"Letter to the editor: case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir\/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Kim","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0350","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0355","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/ijmr.IJMR_502_20","article-title":"Lopinavir\/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: protocol for restricted public health emergency use","volume":"151","author":"Bhatnagar","year":"2020","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0360","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3346\/jkms.2020.35.e79","article-title":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir\/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb0365","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ane.12629","article-title":"The mechanisms of sudden-onset type adverse reactions to oseltamivir","volume":"135","author":"Hama","year":"2017","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0370","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0375","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jmv.25761","article-title":"The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase","volume":"92","author":"Lung","year":"2020","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0380","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"22","key":"10.1016\/j.ijbiomac.2020.09.204_bb0385","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/asia.201900841","article-title":"New nucleoside analogues for the treatment of hemorrhagic fever virus infections","volume":"14","author":"De Clercq","year":"2019","journal-title":"Chem. Asian J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb0390","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0395","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMsr1408795","article-title":"Middle East respiratory syndrome","volume":"376","author":"Arabi","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.09.204_bb0400","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0405","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/srep28698","article-title":"Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients","volume":"6","author":"Menzel","year":"2016","journal-title":"Sci. Rep."},{"issue":"50","key":"10.1016\/j.ijbiomac.2020.09.204_bb0415","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0420","doi-asserted-by":"crossref","DOI":"10.4172\/1948-5964.1000173","article-title":"Azithromycin inhibits the replication of Zika virus","volume":"10","author":"Bosseboeuf","year":"2018","journal-title":"Journal of Antivirals & Antiretrovirals"},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.09.204_bb0425","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola virus inhibitors for drug repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect Dis"},{"issue":"19","key":"10.1016\/j.ijbiomac.2020.09.204_bb0430","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jama.2015.13896","article-title":"Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial","volume":"314","author":"Bacharier","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0435","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0440","first-page":"10.23812","article-title":"Dexamethasone for COVID-19? Not so fast","volume":"34","author":"Theoharides","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0445","doi-asserted-by":"crossref","first-page":"101205","DOI":"10.1016\/j.rmcr.2020.101205","article-title":"Dexamethasone in severe COVID-19 infection: a case series","author":"Hassan","year":"2020","journal-title":"Respiratory Medicine Case Reports"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0450","first-page":"1","article-title":"Dexamethasone nanomedicines for COVID-19","author":"Lammers","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0455","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/nn4048205","article-title":"Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes","volume":"8","author":"Quan","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(18)30346-2","article-title":"Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study","volume":"6","author":"Gouglas","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2020.100124","article-title":"From SARS to COVID-19: a previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans \u2013 call for a one health approach","volume":"9","author":"El Zowalaty","year":"2020","journal-title":"One Health"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0470","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/22221751.2020.1737580","article-title":"Timely development of vaccines against SARS-CoV-2","volume":"9","author":"Lu","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0475","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fmicb.2019.01781","article-title":"Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus","volume":"10","author":"Yong","year":"2019","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb0480","article-title":"Bacterial outer membrane vesicles (OMVs)-based dual vaccine for influenza A H1N1 virus and MERS-CoV","volume":"7","author":"Shehata","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/v11010074","article-title":"Middle East respiratory syndrome vaccine candidates: cautious optimism","volume":"11","author":"Schindewolf","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0495","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/jmv.25820","article-title":"Detection of antibodies against SARS-CoV-2 in patients with COVID-19","volume":"92","author":"Du","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0500","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(20)30567-5","article-title":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","volume":"395","author":"Anderson","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.09.204_bb0505","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS\u2010CoV\u20102 and mechanisms of immunopathological changes in COVID\u201019","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0510","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00151-8","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0515","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfma.2020.02.009","article-title":"SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics","volume":"119","author":"Cao","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0525","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chom.2018.12.006","article-title":"Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens","volume":"25","author":"Netea","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0530","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1093\/infdis\/jiw352","article-title":"Whole-inactivated and virus-like particle vaccine strategies for Chikungunya virus","volume":"214","author":"DeZure","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0535","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.vaccine.2004.11.075","article-title":"Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys","volume":"23","author":"Zhou","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0540","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1099\/vir.0.81579-0","article-title":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus","volume":"87","author":"See","year":"2006","journal-title":"The Journal of general virology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.09.204_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004007","article-title":"Extended preclinical safety, efficacy and stability testing of a live-attenuated Chikungunya vaccine candidate","volume":"9","author":"Plante","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0550","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3389\/fmicb.2019.02881","article-title":"Recent progress in vaccine development against Chikungunya virus","volume":"10","author":"Gao","year":"2019","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0555","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0560","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Guroff","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb0565","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.ijbiomac.2020.09.204_bb0570","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virusres.2007.01.021","article-title":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease","volume":"133","author":"Enjuanes","year":"2008","journal-title":"Virus Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2020.09.204_bb0580","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2005.02.009","article-title":"Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats","volume":"112","author":"Liu","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0585","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0590","series-title":"Advances in Genetics","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.adgen.2014.10.005","article-title":"Chapter seven - self-amplifying mRNA vaccines","author":"Brito","year":"2015"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0595","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2019.10.045","article-title":"Recent advances on HIV DNA vaccines development: stepwise improvements to clinical trials","volume":"316","author":"Rezaei","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0600","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.drudis.2019.12.003","article-title":"Comparison of DNA and mRNA vaccines against cancer","volume":"25","author":"Jahanafrooz","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0605","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0610","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2147\/IJN.S39810","article-title":"Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles","volume":"9","author":"Gasc\u00f3n","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijid.2016.02.083","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in non-human primates","volume":"45","author":"Muthumani","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0620","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0625","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Adnan Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0630","doi-asserted-by":"crossref","DOI":"10.1586\/14760584.2016.1167603","article-title":"Vaccines for the prevention against the threat of MERS-CoV","volume":"15","author":"Du","year":"2016","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0635","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb0640","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0645","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0650","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.2015.1092518","article-title":"Middle East respiratory syndrome: current status and future prospects for vaccine development","volume":"15","author":"Du","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.09.204_bb0660","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1080\/21645515.2017.1358325","article-title":"Vaccines for emerging infectious diseases: lessons from MERS coronavirus and Zika virus","volume":"13","author":"Maslow","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13473","article-title":"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.ijbiomac.2020.09.204_bb0670","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.vaccine.2006.01.058","article-title":"Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates","volume":"24","author":"Liu","year":"2006","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.ijbiomac.2020.09.204_bb0675","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1016\/j.vaccine.2009.05.073","article-title":"Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice","volume":"27","author":"Zheng","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.09.204_bb0680","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/JCM.43.8.3718-3726.2005","article-title":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus","volume":"43","author":"He","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0685","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus\u2013host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0690","article-title":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0695","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.04.01","article-title":"Harnessing the immune system to improve cancer therapy","volume":"4","author":"Papaioannou","year":"2016","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0700","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0710","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0715","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0720","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0725","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00446-15","article-title":"Passive immunotherapy with dromedary immune serum in an experimental animal model for MERS coronavirus infection","volume":"89","author":"Zhao","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0730","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0735","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0740","series-title":"Effect of Treatment With Inosine Pranobex in Acute Respiratory Viral Infections in Children","first-page":"490","volume":"vol. 13","author":"Abaturov","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0745","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/vim.2011.0024","article-title":"Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection","volume":"24","author":"Wang","year":"2011","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0750","first-page":"10","article-title":"Perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (COVID-19)","volume":"38","author":"Shanmugaraj","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0755","series-title":"Therapeutic Approaches for COVID-19 Based on the Dynamics of Interferon-mediated Immune Responses","author":"Nezhad","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0760","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PCC.0000000000001489","article-title":"Distinguishing the effects of inhaled nitric oxide and lung recruitment in pediatric acute respiratory distress syndrome: scope for further improvement","volume":"19","author":"Miyoshi","year":"2018","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0765","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nrmicro1004","article-title":"Antimicrobial reactive oxygen and nitrogen species: concepts and controversies","volume":"2","author":"Fang","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0770","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7150\/ijms.3880","article-title":"Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza","volume":"9","author":"Darwish","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0775","first-page":"1","article-title":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.09.204_bb0780","doi-asserted-by":"crossref","first-page":"e01303","DOI":"10.1128\/mBio.01303-15","article-title":"Reply to \"statins may decrease the fatality rate of MERS infection\"","volume":"6","author":"Totura","year":"2015","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb0785","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","article-title":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","volume":"88","author":"DeDiego","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0790","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/JPR.S228577","article-title":"Role of melatonin in the regulation of pain","volume":"13","author":"Xie","year":"2020","journal-title":"J. Pain Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.09.204_bb0795","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1080\/15548627.2018.1490852","article-title":"Effects of AANAT overexpression on the inflammatory responses and autophagy activity in the cellular and transgenic animal levels","volume":"14","author":"Tao","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0800","doi-asserted-by":"crossref","first-page":"43","DOI":"10.32794\/mr11250047","article-title":"Treatment of ebola and other infectious diseases: melatonin \u201cgoes viral\u201d","volume":"3","author":"Reiter","year":"2020","journal-title":"Melatonin Research"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0805","doi-asserted-by":"crossref","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: melatonin as a potential adjuvant treatment","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0810","doi-asserted-by":"crossref","DOI":"10.5966\/sctm.2015-0021","article-title":"In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome","volume":"4","author":"Simonson","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb0815","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cmi.12522","article-title":"Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta-defensin-2 via toll-like receptor 4 signalling","volume":"18","author":"Sung","year":"2016","journal-title":"Cell. Microbiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.09.204_bb0820","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase\u2013mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.09.204_bb0825","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ajpath.2012.08.009","article-title":"Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis","volume":"181","author":"dos Santos","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0830","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0835","doi-asserted-by":"crossref","first-page":"201601911","DOI":"10.1073\/pnas.1601911113","article-title":"Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo","volume":"113","author":"Chan","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0840","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0845","article-title":"Personalized pharmacological therapy for ARDS: a light at the end of the tunnel","volume":"29","author":"Silva","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0850","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0855","doi-asserted-by":"crossref","DOI":"10.2174\/1574888X09666140228144812","article-title":"Therapeutic potential and mechanisms of action of mesenchymal stromal cells for acute respiratory distress syndrome","volume":"9","author":"Curley","year":"2014","journal-title":"Current stem cell research & therapy"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0860","first-page":"8","article-title":"Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0865","first-page":"90","article-title":"Advance on human umbilical cord mesenchymal stem cells for treatment of ALI in severe burns","volume":"29","author":"Wang","year":"2017","journal-title":"Zhonghua wei zhong bing ji jiu yi xue"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb0870","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","article-title":"Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury","volume":"175","author":"Moodley","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0875","doi-asserted-by":"crossref","first-page":"39889","DOI":"10.1038\/srep39889","article-title":"Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb0880","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/01902148.2017.1300713","article-title":"Effects of human umbilical cord blood mononuclear cells on respiratory system mechanics in a murine model of neonatal lung injury","volume":"43","author":"Mills","year":"2017","journal-title":"Exp. Lung Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.09.204_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040689","article-title":"Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury","volume":"18","author":"Xiang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0890","first-page":"1","article-title":"The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome","volume":"84","author":"Antebi","year":"2017","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0895","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/CCM.0b013e3181eaa5bf","article-title":"Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients","volume":"38","author":"Ong","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0900","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jcyt.2016.09.003","article-title":"Genetically modified mesenchymal stromal cells in cancer therapy","volume":"18","author":"Sage","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0905","doi-asserted-by":"crossref","first-page":"e83303","DOI":"10.1371\/journal.pone.0083303","article-title":"Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0910","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/ijms15021719","article-title":"Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases","volume":"15","author":"Wyse","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0915","doi-asserted-by":"crossref","DOI":"10.1002\/sctm.18-0236","article-title":"Mesenchymal stem cells reconditioned in their own serum exhibit augmented therapeutic properties in the setting of acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0920","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/jcm8060847","article-title":"Overexpression of IL-10 enhances the efficacy of human umbilical-cord-derived mesenchymal stromal cells in E. coli pneumosepsis","volume":"8","author":"Jerkic","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0925","article-title":"Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells","volume":"25","author":"Wang","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0930","first-page":"195","article-title":"Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4","author":"Fang","year":"2015","journal-title":"Journal of immunology (Baltimore,Md.: 1950)"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0935","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/thoraxjnl-2011-201176","article-title":"Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia","volume":"67","author":"Gupta","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0940","first-page":"18","article-title":"Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta-defensin-2 via toll like receptor 4 signaling","author":"Sung","year":"2015","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0945","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0921-x","article-title":"Therapeutic potential of products derived from mesenchymal stem\/stromal cells in pulmonary disease","volume":"19","author":"Mohammadipoor","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0950","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40169-019-0242-9","article-title":"Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options","volume":"8","author":"Shah","year":"2019","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0955","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0960","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/JCMA.0000000000000318","article-title":"Potential therapeutic agents against COVID-19: what we know so far","volume":"83","author":"Lu","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0965","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0970","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jconrel.2020.02.027","article-title":"Recent advances in nanotechnology-based drug delivery systems for the kidney","volume":"321","author":"Oroojalian","year":"2020","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.09.204_bb0975","doi-asserted-by":"crossref","first-page":"17194","DOI":"10.1002\/jcb.28980","article-title":"Synthesis and evaluation of injectable thermosensitive penta-block copolymer hydrogel (PNIPAAm-PCL-PEG-PCL-PNIPAAm) and star-shaped poly (CLCOLA)-b-PEG for wound healing applications","volume":"120","author":"Oroojalian","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0980","first-page":"1","article-title":"Nanotechnology and medicine - the upside and the downside","volume":"5","author":"Shubhika","year":"2013","journal-title":"International Journal of Drug Development and Research"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0985","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","article-title":"Applications of nanoparticle systems in drug delivery technology","volume":"26","author":"Rizvi","year":"2018","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0990","doi-asserted-by":"crossref","first-page":"17577","DOI":"10.3390\/ijms151017577","article-title":"Right or left: the role of nanoparticles in pulmonary diseases","volume":"15","author":"Lu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb0995","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00212813","article-title":"Medical nanoparticles for next generation drug delivery to the lungs","volume":"44","author":"van Rijt","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"2224","key":"10.1016\/j.ijbiomac.2020.09.204_bb1000","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"issue":"42","key":"10.1016\/j.ijbiomac.2020.09.204_bb1005","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.2174\/1381612821666151027153410","article-title":"Synthetic and biological vesicular nano-carriers designed for gene delivery","volume":"21","author":"Soltani","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb1010","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/21691401.2017.1376675","article-title":"Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment","volume":"46","author":"Afsharzadeh","year":"2018","journal-title":"Artificial Cells, Nanomedicine and Biotechnology"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1015","first-page":"12","article-title":"Nanomedicine for infectious disease applications: innovation towards broad-spectrum treatment of viral infections","author":"Jackman","year":"2015","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.02.012","article-title":"MERS-CoV spike nanoparticles protect mice from MERS-CoV infection","volume":"35","author":"Coleman","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.04.082","article-title":"Heterologous prime\u2013boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus","volume":"36","author":"Jung","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1035","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2147\/IJN.S31379","article-title":"A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide","volume":"7","author":"Roh","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trac.2017.10.005","article-title":"Nanomaterial-based biosensors for detection of pathogenic virus","volume":"97","author":"Mokhtarzadeh","year":"2017","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1045","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijbiomac.2018.03.183","article-title":"An innovative immunosensor for ultrasensitive detection of breast cancer specific carbohydrate (CA 15-3) in unprocessed human plasma and MCF-7 breast cancer cell lysates using gold nanospear electrochemically assembled onto thiolated graphene quantum dots","volume":"114","author":"Hasanzadeh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.trac.2017.11.012","article-title":"Recent trends in rapid detection of influenza infections by bio and nanobiosensor","volume":"98","author":"Hassanpour","year":"2018","journal-title":"TrAC Trends Anal. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.09.204_bb1055","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1007\/s10854-016-4590-6","article-title":"Graphene quantum dot as an electrically conductive material toward low potential detection: a new platform for interface science","volume":"27","author":"Hasanzadeh","year":"2016","journal-title":"J. Mater. Sci. Mater. Electron."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/nn900086c","article-title":"Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes","volume":"3","author":"Ishikawa","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1065","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.7b00255","article-title":"Multiplex paper-based colorimetric DNA sensor using pyrrolidinyl peptide nucleic acid-induced AgNPs aggregation for detecting MERS-CoV, MTB, and HPV oligonucleotides","volume":"89","author":"Teengam","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2020.09.204_bb1070","article-title":"Development of label-free colorimetric assay for MERS-CoV using gold nanoparticles","volume":"4","author":"Kim","year":"2019","journal-title":"ACS Sensors"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.09.204_bb1075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","article-title":"Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine","volume":"73","author":"Pimentel","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.09.204_bb1080","article-title":"Progress and prospects on vaccine development against SARS-CoV-2","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.09.204_bb1085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent Sci"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.09.204_bb1090","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.3346\/jkms.2020.35.e61","article-title":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures","volume":"35","author":"Kim","year":"2020","journal-title":"J. Korean Med. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020345645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020345645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:11:53Z","timestamp":1758874313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020345645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":218,"alternative-id":["S0141813020345645"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.204","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}